Antidiabetics Market Analysis by Industry experts | Sanofi Aventis, Takeda Pharmaceutical, Eli Lilly, Oramed Pharmaceuticals Inc., Boehringer Ingelheim, Merck & Co. Inc., Novo Nordisk, Bristol-Myers Squibb, Halozyme Therapeutics, Pfizer, AstraZeneca, John
Growing geriatric population along with escalating diabetes prevalence across the globe should drive the antidiabetics market size. According to WHO, diabetes will be the among the leading causes of death by 2030 which poses a major burden on the healthcare systems. These factors will have a positive impact on the global usage of insulin as well as other antidiabetics including DPP-4 and GLP-1 over the forecast period.
Rising geriatric population base, innovation of new drugs, increasing adoption of drugs and increased disposable income should further drive industry growth. Owing to the changes in lifestyle, even children between age group of 13-14 years are at high risk to get diabetes. It offers huge opportunities industry players.
Request sample copy of this report @ https://www.gminsights.com/request-sample/detail/504
Some of the companies operating in antidiabetics market include :-
• Sanofi Aventis
• Takeda Pharmaceutical
• Eli Lilly
• Oramed Pharmaceuticals Inc.
• Boehringer Ingelheim
• Merck & Co. Inc.
• Novo Nordisk
• Bristol-Myers Squibb
• Halozyme Therapeutics
• Johnson & Johnson
• Novartis AG
• Bayer Corporation
Extensive product portfolio and rising R&D investment for producing innovative and pipeline products are the major strategies adopted by these players to maintain their market share. Other active players in the market include Takeda Pharmaceuticals, Merck, Boehringer Ingelheim and Bristol-Myers Squibb. New industry players are trying to exploit the lucrative market by developing cost-effective biosimilars to reduce the excessive cost barrier for effective diabetes management.
Make Inquiry about this report @ https://www.gminsights.com/inquiry-before-buying/504
Favorable government initiatives such as Diabetes Prevention Program (DPP) that aims to help individuals with prediabetes, reduces their risk to develop type 2 diabetes. Trained lifestyle coach works with participants and communicate lifestyle skills, such as, eating healthy food, physical activity and managing stress. Such initiatives should propel industry growth over the forecast period.
Advent of new technologies in products like long acting insulin analogs as well as rapid acting with increased effectiveness should drive industry growth over the forecast timeframe. The novel insulin pen technology permits low-pain and suitable daily insulin injection that should upsurge therapy sales. Type 2 diabetes mellitus (T2DM) has strong familial aggregation, the person with a parent or sibling with disease are at high risk. People with obesity, hypertension, or dyslipidemia and women with history of gestational diabetes are also at high risk to develop T2DM.
Long-acting insulin provide basal insulin coverage. Basal insulin suppresses hepatic gluconeogenesis and prevent increase in glucose level during fasting state in insulin-deficient patients. Long acting insulin analog includes insulin glargine (Lantus) and insulin detemir (Levemir) which will drive industry growth.
Biguanides should contribute for significant revenue share in 2016. It is colorless solid and prevents production of glucose in liver. Biguanides are administered orally for the treatment of type 2 diabetes. It helps in improving sensitivity of body towards insulin and decreases amount of sugar absorbed in intestines and will increase demand for such antidiabetic drugs.
UK contributed for significant revenue share in 2016. The growth is attributed due to wide range of funds offered by Diabetes UK for research related to the treatment of diabetes and its complications. In November 2016, the Prime Minister introduced new Diabetes UK office on World Diabetes Day.
U.S. antidiabetics market size valued over USD 19.4 billion in 2016 and expected to grow significantly over the coming years. Increased healthcare expenditure along with availability of improved healthcare infrastructure and favorable reimbursement policies should drive antidiabetics market size.
Japan antidiabetics market should grow at significant rate over the forecast period. Diabetic population is on rise due to lifestyle changes that will accompany economic growth and drive antidiabetic market growth. The Japan Diabetes Society (JDS) encourage progress and development of diabetes study and prevent people from disease in the country.
Brazil contributed for significant revenue share. The growth is attributed due to early adoption of insulin analogues and increased use of these products in the country.
Antidiabetics market by product
o Rapid acting
o Long acting
o Premixed insulin
o Premixed analog
o Short Acting
o Intermediate acting
o Alpha-glucosidase inhibitors
o GLP-1 agonist
o DPP-4 inhibitors
o SGLT – 2
Antidiabetics market by application
o Type I Diabetes
o Type II & Other
Global Market Insights, Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider; offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy and biotechnology.
Corporate Sales, USA
Global Market Insights, Inc.
Toll Free: 1-888-689-0688
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Antidiabetics Market Analysis by Industry experts | Sanofi Aventis, Takeda Pharmaceutical, Eli Lilly, Oramed Pharmaceuticals Inc., Boehringer Ingelheim, Merck & Co. Inc., Novo Nordisk, Bristol-Myers Squibb, Halozyme Therapeutics, Pfizer, AstraZeneca, John here
News-ID: 1333208 • Views: 595
More Releases from Global Market Insights, Inc.
Hypochlorite Bleaches Market to hit US$ 300 Mn 2025 | Top Key Players like Adity …
As per the research report by Global Market Insights, Inc., Global Hypochlorite Bleaches Market to cross USD 300 million by 2025 and grow at 3.4% CAGR from 2019 to 2025. It has been projected that the Global hypochlorite bleaches market is expected to reach a consumption of around 485-kilo tons by 2025. Water scarcity as well as rising water costs have led to more emphasis being laid on water recycling and
Feminine Hygiene Products Market: Growing awareness regarding intimate health in …
Global Market Insights, Inc., announces an ongoing comprehensive report on the Feminine Hygiene Products Market. One of the most hushed topics across the world is female hygiene, the negligence of which results in several diseases. Studies claim that nearly 30% to 60 % women across the globe develop urinary tract infection once in their lifetime, mainly due to negligence in proper intimate hygiene. Dearth of knowledge regarding the negative consequences of
Examination Gowns Market 2020 business trends & growth opportunities to 2026
Global Market Insights, Inc., announces an ongoing comprehensive report on the Examination Gowns Market. The exposure to various kinds of hospital acquired infections has led to a spate of health problems for the healthcare professionals as well has the patients. In this regard, experts have been massively shifting to adoption of personal protective equipment or clothing, examination gowns, protecting them from all kinds of infections. These gowns are present in the
Nonwoven Packaging Market to witness increased demand from pharmaceutical sector …
Global Market Insights, Inc., announces an ongoing comprehensive report on the Nonwoven Packaging Market. With the world struggling to fight against negative consequences of industrialization and increased carbon emissions, nonwovens or nonwoven fabrics have emerged as an intrinsic solution for all ecological imbalances across the globe. These fabrics are made from staple fiber and long fibers, merged together by chemical, heat, or mechanical treatment. These are generally used in textile manufacturing
More Releases for Antidiabetics
US Antidiabetics Drug Market Outlook 2022 Report
“US Antidiabetics Drug Market Outlook 2022” report highlights: * US Diabetes Epidemiology * US Antidiabetics Market Overview * Key Marketed Antidiabetic Drugs in US * US Biosimilar Insulin Market * US Antidiabetics Drug Market Future Prospects Download Report Sample Weblink: https://www.kuickresearch.com/report-us-antidiabetics-drug-market-outlook-2022.php For Report Sample Contact: firstname.lastname@example.org Table of Contents Antidiabetics: Regimen for Diabetes Mellitus 1.1 Prologue Towards Diabetes 1.2 Preface to Antidiabetics Antiquity of Managing Diabetes Mellitus 2.1 Trajectory from Diabetes to Insulin
US Antidiabetics Drug Market Outlook 2022 Report Download
“US Antidiabetics Drug Market Outlook 2022” report gives clinical and non-clinical insight on trends associated with the development of Antidiabetics drug market in US. Report helps to identify the diabetes epidemiology (Prevalence of Type 1 and 2 Diabetes) in the US market along with the associated economic burden and productivity loss. “US Antidiabetics Drug Market Outlook 2022” report highlights: * US Diabetes Epidemiology * US Antidiabetics Market Overview * Key Marketed Antidiabetic Drugs
Antidiabetics Market Intelligence with Competitive Landscape 2023
The anti-diabetics market includes drugs, which are used for treatment of diabetes mellitus and are also known as oral hypoglycemic/antihyperglycemic agents. The anti-diabetics market has grown tremendously in recent years with increasing prevalence of diabetes mellitus. Thus, systemic therapies for diabetes have become the focal point of attention due to the burgeoning diabetic population size, with diabetes affecting middle age groups and children across all income groups globally. The anti-diabetics market
Global Antidiabetics Drug Market Size - Industry Analysis And Forecast
Latest industry research report on: Global Antidiabetics Drug Market | Industry Size, Share, Research, Reviews, Analysis, Strategies, Demand, Growth, Segmentation, Parameters, Forecasts Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Antidiabetics Drug in these regions, from 2012 to 2022 (forecast), covering North America Europe China Japan Southeast Asia India Request For Sample Report @https://www.marketresearchreports.biz/sample/sample/1270897 Global Antidiabetics Drug market competition by top manufacturers, with production, price, revenue
US Antidiabetics Drug Market US Antidiabetics Clinical Pipeline Report 2022
For Report Sample Contact: email@example.com or +91-11-47067990 Report Table of Contents Antidiabetics: Regimen for Diabetes Mellitus 1.1 Prologue Towards Diabetes 1.2 Preface to Antidiabetics Antiquity of Managing Diabetes Mellitus 2.1 Trajectory from Diabetes to Insulin 2.2 Historical En Route towards Oral Diabetic Medication Treatments Available for Diabetes Mellitus 3.1 Non-Pharmacological Approaches for Diabetes Mellitus 3.2 Pharmacological Approaches for Diabetes Mellitus Cataloguing of Antidiabetic Agents 4.1
US To Dominate Global Antidiabetics Drug Market
“US Antidiabetics Drug Market Outlook 2022” report highlights: * US Diabetes Epidemiology * US Antidiabetics Market Overview * Key Marketed Antidiabetic Drugs in US * US Biosimilar Insulin Market * US Antidiabetics Drug Market Future Prospects For Report Sample Contact: firstname.lastname@example.org or +91-11-47067990 Download Report: https://www.kuickresearch.com/report-us-antidiabetics-drug-market-outlook-2022.php Report Table of Contents Antidiabetics: Regimen for Diabetes Mellitus 1.1 Prologue Towards Diabetes 1.2 Preface to Antidiabetics Antiquity of Managing Diabetes Mellitus 2.1 Trajectory from Diabetes to Insulin